Loading…

Simultaneous Administration of ADSCs-Based Therapy and Gene Therapy Using Ad-huPA Reduces Experimental Liver Fibrosis

hADSCs transplantation in cirrhosis models improves liver function and reduces fibrosis. In addition, Ad-huPA gene therapy diminished fibrosis and increased hepatocyte regeneration. In this study, we evaluate the combination of these therapies in an advanced liver fibrosis experimental model. hADSCs...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2016-12, Vol.11 (12), p.e0166849-e0166849
Main Authors: Meza-Ríos, Alejandra, García-Benavides, Leonel, García-Bañuelos, Jesus, Salazar-Montes, Adriana, Armendáriz-Borunda, Juan, Sandoval-Rodríguez, Ana
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c725t-785b1c119a5d9142e14747864d120f6cd967cd56d0e8ab9f91b4516cc355957a3
cites cdi_FETCH-LOGICAL-c725t-785b1c119a5d9142e14747864d120f6cd967cd56d0e8ab9f91b4516cc355957a3
container_end_page e0166849
container_issue 12
container_start_page e0166849
container_title PloS one
container_volume 11
creator Meza-Ríos, Alejandra
García-Benavides, Leonel
García-Bañuelos, Jesus
Salazar-Montes, Adriana
Armendáriz-Borunda, Juan
Sandoval-Rodríguez, Ana
description hADSCs transplantation in cirrhosis models improves liver function and reduces fibrosis. In addition, Ad-huPA gene therapy diminished fibrosis and increased hepatocyte regeneration. In this study, we evaluate the combination of these therapies in an advanced liver fibrosis experimental model. hADSCs were expanded and characterized before transplantation. Ad-huPA was simultaneously administrated via the ileac vein. Animals were immunosuppressed by CsA 24 h before treatment and until sacrifice at 10 days post-treatment. huPA liver expression and hADSCs biodistribution were evaluated, as well as the percentage of fibrotic tissue, hepatic mRNA levels of Col-αI, TGF-β1, CTGF, α-SMA, PAI-I, MMP2 and serum levels of ALT, AST and albumin. hADSCs homed mainly in liver, whereas huPA expression was similar in Ad-huPA and hADSCs/Ad-huPA groups. hADSCs, Ad-huPA and hADSCs/Ad-huPA treatment improves albumin levels, reduces liver fibrosis and diminishes Collagen α1, CTGF and α-SMA mRNA liver levels. ALT and AST serum levels showed a significant decrease exclusively in the hADSCs group. These results showed that combinatorial effect of cell and gene-therapy does not improve the antifibrogenic effects of individual treatments, whereas hADSCs transplantation seems to reduce liver fibrosis in a greater proportion.
doi_str_mv 10.1371/journal.pone.0166849
format article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1849689202</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A474078695</galeid><doaj_id>oai_doaj_org_article_5953da0dcbad412abf61663de0d49278</doaj_id><sourcerecordid>A474078695</sourcerecordid><originalsourceid>FETCH-LOGICAL-c725t-785b1c119a5d9142e14747864d120f6cd967cd56d0e8ab9f91b4516cc355957a3</originalsourceid><addsrcrecordid>eNqNk11v0zAUhiMEYqPwDxBEQkJwkeKvOPENUijbqFRpaN24tRzbaV0lcWcn0_bvcWlWNWgXUy4SnTzn9Tnv8Ymi9xBMIc7gt43tXSvq6da2egogpTlhL6JTyDBKKAL45dH3SfTG-w0AKc4pfR2doIwxRHB-GvVL0_R1J1ptex8XqjGt8Z0TnbFtbKu4-Lmc-eSH8FrF12vtxPYhFq2KL3SrD4Ebb9pVSE7W_e8ivtKql9rHZ_db7Uyj207U8cLcaRefm9JZb_zb6FUlaq_fDe9JdHN-dj37lSwuL-azYpHIDKVdkuVpCSWETKSKQYI0JBnJckoURKCiUjGaSZVSBXQuSlYxWJIUUilxmrI0E3gSfdzrbmvr-eCY5zBYRXOGAArEfE8oKzZ8G-oV7oFbYfi_gHUrLlxnZK15kMRKACVLoQhEoqxocB0rDRRhKMuD1vfhtL5stJKhcyfqkej4T2vWfGXveKgZYgyCwJdBwNnbXvuON8ZLXdf78YS6U0YygMCzUIgYJjAL6Kf_0KeNGKiVCL2atrKhRLkT5UVwHQTbQ_-TaPoEFR6lGyPDTaxMiI8Svo4SAtPp-24leu_5fHn1fPbyz5j9fMSutai7tbd1v7u3fgySPSjDzfNOV4d5QMB3i_ToBt8tEh8WKaR9OJ7lIelxc_BfE80XPA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1849689202</pqid></control><display><type>article</type><title>Simultaneous Administration of ADSCs-Based Therapy and Gene Therapy Using Ad-huPA Reduces Experimental Liver Fibrosis</title><source>ProQuest - Publicly Available Content Database</source><source>PubMed Central</source><creator>Meza-Ríos, Alejandra ; García-Benavides, Leonel ; García-Bañuelos, Jesus ; Salazar-Montes, Adriana ; Armendáriz-Borunda, Juan ; Sandoval-Rodríguez, Ana</creator><contributor>Avila, Matias A.</contributor><creatorcontrib>Meza-Ríos, Alejandra ; García-Benavides, Leonel ; García-Bañuelos, Jesus ; Salazar-Montes, Adriana ; Armendáriz-Borunda, Juan ; Sandoval-Rodríguez, Ana ; Avila, Matias A.</creatorcontrib><description>hADSCs transplantation in cirrhosis models improves liver function and reduces fibrosis. In addition, Ad-huPA gene therapy diminished fibrosis and increased hepatocyte regeneration. In this study, we evaluate the combination of these therapies in an advanced liver fibrosis experimental model. hADSCs were expanded and characterized before transplantation. Ad-huPA was simultaneously administrated via the ileac vein. Animals were immunosuppressed by CsA 24 h before treatment and until sacrifice at 10 days post-treatment. huPA liver expression and hADSCs biodistribution were evaluated, as well as the percentage of fibrotic tissue, hepatic mRNA levels of Col-αI, TGF-β1, CTGF, α-SMA, PAI-I, MMP2 and serum levels of ALT, AST and albumin. hADSCs homed mainly in liver, whereas huPA expression was similar in Ad-huPA and hADSCs/Ad-huPA groups. hADSCs, Ad-huPA and hADSCs/Ad-huPA treatment improves albumin levels, reduces liver fibrosis and diminishes Collagen α1, CTGF and α-SMA mRNA liver levels. ALT and AST serum levels showed a significant decrease exclusively in the hADSCs group. These results showed that combinatorial effect of cell and gene-therapy does not improve the antifibrogenic effects of individual treatments, whereas hADSCs transplantation seems to reduce liver fibrosis in a greater proportion.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0166849</identifier><identifier>PMID: 27992438</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Adipose Tissue - cytology ; Albumin ; Animals ; Biology and Life Sciences ; Care and treatment ; Cell Differentiation ; Chemokines ; Cirrhosis ; Collagen ; Combinatorial analysis ; Combined Modality Therapy ; Connective tissue growth factor ; Control ; Data collection ; Dependovirus - genetics ; Fibrosis ; Gelatinase A ; Gene expression ; Gene therapy ; Genetic Therapy - methods ; Genetic Vectors - administration &amp; dosage ; Genomics ; Growth factors ; Health sciences ; Humans ; Liver ; Liver cirrhosis ; Liver Cirrhosis, Experimental - genetics ; Liver Cirrhosis, Experimental - therapy ; Liver transplants ; Male ; Medicine ; Medicine and Health Sciences ; Molecular biology ; mRNA ; Rats ; Rats, Wistar ; Regeneration ; Research and Analysis Methods ; Serum levels ; Stem cells ; Stromal Cells - transplantation ; Studies ; Tissue transplantation ; Transforming growth factor-b1 ; Transplantation ; Transplants &amp; implants ; Treatment Outcome ; Urokinase-Type Plasminogen Activator - genetics ; Vectors (Biology)</subject><ispartof>PloS one, 2016-12, Vol.11 (12), p.e0166849-e0166849</ispartof><rights>COPYRIGHT 2016 Public Library of Science</rights><rights>2016 Meza-Ríos et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2016 Meza-Ríos et al 2016 Meza-Ríos et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c725t-785b1c119a5d9142e14747864d120f6cd967cd56d0e8ab9f91b4516cc355957a3</citedby><cites>FETCH-LOGICAL-c725t-785b1c119a5d9142e14747864d120f6cd967cd56d0e8ab9f91b4516cc355957a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1849689202/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1849689202?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27992438$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Avila, Matias A.</contributor><creatorcontrib>Meza-Ríos, Alejandra</creatorcontrib><creatorcontrib>García-Benavides, Leonel</creatorcontrib><creatorcontrib>García-Bañuelos, Jesus</creatorcontrib><creatorcontrib>Salazar-Montes, Adriana</creatorcontrib><creatorcontrib>Armendáriz-Borunda, Juan</creatorcontrib><creatorcontrib>Sandoval-Rodríguez, Ana</creatorcontrib><title>Simultaneous Administration of ADSCs-Based Therapy and Gene Therapy Using Ad-huPA Reduces Experimental Liver Fibrosis</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>hADSCs transplantation in cirrhosis models improves liver function and reduces fibrosis. In addition, Ad-huPA gene therapy diminished fibrosis and increased hepatocyte regeneration. In this study, we evaluate the combination of these therapies in an advanced liver fibrosis experimental model. hADSCs were expanded and characterized before transplantation. Ad-huPA was simultaneously administrated via the ileac vein. Animals were immunosuppressed by CsA 24 h before treatment and until sacrifice at 10 days post-treatment. huPA liver expression and hADSCs biodistribution were evaluated, as well as the percentage of fibrotic tissue, hepatic mRNA levels of Col-αI, TGF-β1, CTGF, α-SMA, PAI-I, MMP2 and serum levels of ALT, AST and albumin. hADSCs homed mainly in liver, whereas huPA expression was similar in Ad-huPA and hADSCs/Ad-huPA groups. hADSCs, Ad-huPA and hADSCs/Ad-huPA treatment improves albumin levels, reduces liver fibrosis and diminishes Collagen α1, CTGF and α-SMA mRNA liver levels. ALT and AST serum levels showed a significant decrease exclusively in the hADSCs group. These results showed that combinatorial effect of cell and gene-therapy does not improve the antifibrogenic effects of individual treatments, whereas hADSCs transplantation seems to reduce liver fibrosis in a greater proportion.</description><subject>Adipose Tissue - cytology</subject><subject>Albumin</subject><subject>Animals</subject><subject>Biology and Life Sciences</subject><subject>Care and treatment</subject><subject>Cell Differentiation</subject><subject>Chemokines</subject><subject>Cirrhosis</subject><subject>Collagen</subject><subject>Combinatorial analysis</subject><subject>Combined Modality Therapy</subject><subject>Connective tissue growth factor</subject><subject>Control</subject><subject>Data collection</subject><subject>Dependovirus - genetics</subject><subject>Fibrosis</subject><subject>Gelatinase A</subject><subject>Gene expression</subject><subject>Gene therapy</subject><subject>Genetic Therapy - methods</subject><subject>Genetic Vectors - administration &amp; dosage</subject><subject>Genomics</subject><subject>Growth factors</subject><subject>Health sciences</subject><subject>Humans</subject><subject>Liver</subject><subject>Liver cirrhosis</subject><subject>Liver Cirrhosis, Experimental - genetics</subject><subject>Liver Cirrhosis, Experimental - therapy</subject><subject>Liver transplants</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine and Health Sciences</subject><subject>Molecular biology</subject><subject>mRNA</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Regeneration</subject><subject>Research and Analysis Methods</subject><subject>Serum levels</subject><subject>Stem cells</subject><subject>Stromal Cells - transplantation</subject><subject>Studies</subject><subject>Tissue transplantation</subject><subject>Transforming growth factor-b1</subject><subject>Transplantation</subject><subject>Transplants &amp; implants</subject><subject>Treatment Outcome</subject><subject>Urokinase-Type Plasminogen Activator - genetics</subject><subject>Vectors (Biology)</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNqNk11v0zAUhiMEYqPwDxBEQkJwkeKvOPENUijbqFRpaN24tRzbaV0lcWcn0_bvcWlWNWgXUy4SnTzn9Tnv8Ymi9xBMIc7gt43tXSvq6da2egogpTlhL6JTyDBKKAL45dH3SfTG-w0AKc4pfR2doIwxRHB-GvVL0_R1J1ptex8XqjGt8Z0TnbFtbKu4-Lmc-eSH8FrF12vtxPYhFq2KL3SrD4Ebb9pVSE7W_e8ivtKql9rHZ_db7Uyj207U8cLcaRefm9JZb_zb6FUlaq_fDe9JdHN-dj37lSwuL-azYpHIDKVdkuVpCSWETKSKQYI0JBnJckoURKCiUjGaSZVSBXQuSlYxWJIUUilxmrI0E3gSfdzrbmvr-eCY5zBYRXOGAArEfE8oKzZ8G-oV7oFbYfi_gHUrLlxnZK15kMRKACVLoQhEoqxocB0rDRRhKMuD1vfhtL5stJKhcyfqkej4T2vWfGXveKgZYgyCwJdBwNnbXvuON8ZLXdf78YS6U0YygMCzUIgYJjAL6Kf_0KeNGKiVCL2atrKhRLkT5UVwHQTbQ_-TaPoEFR6lGyPDTaxMiI8Svo4SAtPp-24leu_5fHn1fPbyz5j9fMSutai7tbd1v7u3fgySPSjDzfNOV4d5QMB3i_ToBt8tEh8WKaR9OJ7lIelxc_BfE80XPA</recordid><startdate>20161216</startdate><enddate>20161216</enddate><creator>Meza-Ríos, Alejandra</creator><creator>García-Benavides, Leonel</creator><creator>García-Bañuelos, Jesus</creator><creator>Salazar-Montes, Adriana</creator><creator>Armendáriz-Borunda, Juan</creator><creator>Sandoval-Rodríguez, Ana</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20161216</creationdate><title>Simultaneous Administration of ADSCs-Based Therapy and Gene Therapy Using Ad-huPA Reduces Experimental Liver Fibrosis</title><author>Meza-Ríos, Alejandra ; García-Benavides, Leonel ; García-Bañuelos, Jesus ; Salazar-Montes, Adriana ; Armendáriz-Borunda, Juan ; Sandoval-Rodríguez, Ana</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c725t-785b1c119a5d9142e14747864d120f6cd967cd56d0e8ab9f91b4516cc355957a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adipose Tissue - cytology</topic><topic>Albumin</topic><topic>Animals</topic><topic>Biology and Life Sciences</topic><topic>Care and treatment</topic><topic>Cell Differentiation</topic><topic>Chemokines</topic><topic>Cirrhosis</topic><topic>Collagen</topic><topic>Combinatorial analysis</topic><topic>Combined Modality Therapy</topic><topic>Connective tissue growth factor</topic><topic>Control</topic><topic>Data collection</topic><topic>Dependovirus - genetics</topic><topic>Fibrosis</topic><topic>Gelatinase A</topic><topic>Gene expression</topic><topic>Gene therapy</topic><topic>Genetic Therapy - methods</topic><topic>Genetic Vectors - administration &amp; dosage</topic><topic>Genomics</topic><topic>Growth factors</topic><topic>Health sciences</topic><topic>Humans</topic><topic>Liver</topic><topic>Liver cirrhosis</topic><topic>Liver Cirrhosis, Experimental - genetics</topic><topic>Liver Cirrhosis, Experimental - therapy</topic><topic>Liver transplants</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine and Health Sciences</topic><topic>Molecular biology</topic><topic>mRNA</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Regeneration</topic><topic>Research and Analysis Methods</topic><topic>Serum levels</topic><topic>Stem cells</topic><topic>Stromal Cells - transplantation</topic><topic>Studies</topic><topic>Tissue transplantation</topic><topic>Transforming growth factor-b1</topic><topic>Transplantation</topic><topic>Transplants &amp; implants</topic><topic>Treatment Outcome</topic><topic>Urokinase-Type Plasminogen Activator - genetics</topic><topic>Vectors (Biology)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Meza-Ríos, Alejandra</creatorcontrib><creatorcontrib>García-Benavides, Leonel</creatorcontrib><creatorcontrib>García-Bañuelos, Jesus</creatorcontrib><creatorcontrib>Salazar-Montes, Adriana</creatorcontrib><creatorcontrib>Armendáriz-Borunda, Juan</creatorcontrib><creatorcontrib>Sandoval-Rodríguez, Ana</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale_Opposing Viewpoints In Context</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>ProQuest Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>https://resources.nclive.org/materials</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agriculture Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>ProQuest Biological Science Journals</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest advanced technologies &amp; aerospace journals</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials science collection</collection><collection>ProQuest - Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Meza-Ríos, Alejandra</au><au>García-Benavides, Leonel</au><au>García-Bañuelos, Jesus</au><au>Salazar-Montes, Adriana</au><au>Armendáriz-Borunda, Juan</au><au>Sandoval-Rodríguez, Ana</au><au>Avila, Matias A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Simultaneous Administration of ADSCs-Based Therapy and Gene Therapy Using Ad-huPA Reduces Experimental Liver Fibrosis</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2016-12-16</date><risdate>2016</risdate><volume>11</volume><issue>12</issue><spage>e0166849</spage><epage>e0166849</epage><pages>e0166849-e0166849</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>hADSCs transplantation in cirrhosis models improves liver function and reduces fibrosis. In addition, Ad-huPA gene therapy diminished fibrosis and increased hepatocyte regeneration. In this study, we evaluate the combination of these therapies in an advanced liver fibrosis experimental model. hADSCs were expanded and characterized before transplantation. Ad-huPA was simultaneously administrated via the ileac vein. Animals were immunosuppressed by CsA 24 h before treatment and until sacrifice at 10 days post-treatment. huPA liver expression and hADSCs biodistribution were evaluated, as well as the percentage of fibrotic tissue, hepatic mRNA levels of Col-αI, TGF-β1, CTGF, α-SMA, PAI-I, MMP2 and serum levels of ALT, AST and albumin. hADSCs homed mainly in liver, whereas huPA expression was similar in Ad-huPA and hADSCs/Ad-huPA groups. hADSCs, Ad-huPA and hADSCs/Ad-huPA treatment improves albumin levels, reduces liver fibrosis and diminishes Collagen α1, CTGF and α-SMA mRNA liver levels. ALT and AST serum levels showed a significant decrease exclusively in the hADSCs group. These results showed that combinatorial effect of cell and gene-therapy does not improve the antifibrogenic effects of individual treatments, whereas hADSCs transplantation seems to reduce liver fibrosis in a greater proportion.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>27992438</pmid><doi>10.1371/journal.pone.0166849</doi><tpages>e0166849</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2016-12, Vol.11 (12), p.e0166849-e0166849
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_1849689202
source ProQuest - Publicly Available Content Database; PubMed Central
subjects Adipose Tissue - cytology
Albumin
Animals
Biology and Life Sciences
Care and treatment
Cell Differentiation
Chemokines
Cirrhosis
Collagen
Combinatorial analysis
Combined Modality Therapy
Connective tissue growth factor
Control
Data collection
Dependovirus - genetics
Fibrosis
Gelatinase A
Gene expression
Gene therapy
Genetic Therapy - methods
Genetic Vectors - administration & dosage
Genomics
Growth factors
Health sciences
Humans
Liver
Liver cirrhosis
Liver Cirrhosis, Experimental - genetics
Liver Cirrhosis, Experimental - therapy
Liver transplants
Male
Medicine
Medicine and Health Sciences
Molecular biology
mRNA
Rats
Rats, Wistar
Regeneration
Research and Analysis Methods
Serum levels
Stem cells
Stromal Cells - transplantation
Studies
Tissue transplantation
Transforming growth factor-b1
Transplantation
Transplants & implants
Treatment Outcome
Urokinase-Type Plasminogen Activator - genetics
Vectors (Biology)
title Simultaneous Administration of ADSCs-Based Therapy and Gene Therapy Using Ad-huPA Reduces Experimental Liver Fibrosis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T12%3A13%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Simultaneous%20Administration%20of%20ADSCs-Based%20Therapy%20and%20Gene%20Therapy%20Using%20Ad-huPA%20Reduces%20Experimental%20Liver%20Fibrosis&rft.jtitle=PloS%20one&rft.au=Meza-R%C3%ADos,%20Alejandra&rft.date=2016-12-16&rft.volume=11&rft.issue=12&rft.spage=e0166849&rft.epage=e0166849&rft.pages=e0166849-e0166849&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0166849&rft_dat=%3Cgale_plos_%3EA474078695%3C/gale_plos_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c725t-785b1c119a5d9142e14747864d120f6cd967cd56d0e8ab9f91b4516cc355957a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1849689202&rft_id=info:pmid/27992438&rft_galeid=A474078695&rfr_iscdi=true